Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest hepatitis C Stories

2013-01-15 07:15:18

LONDON, January 15, 2013 /PRNewswire/ -- - Experts recommend comprehensive approach to combat global health issue - A new Economist Intelligence Unit (EIU) report titled The Silent Pandemic: Tackling Hepatitis C with Policy Innovation, made possible as a result of an educational grant from Janssen Pharmaceutica NV and published today, highlights the urgent need for countries around the world to develop strategies to tackle head-on the growing social and economic...

2013-01-11 05:03:06

Hepatitiscnews.com will provide practical advice and support to people living with hepatitis C (PRWEB) January 10, 2013 A new website, aimed at providing practical advice and support to people living with hepatitis C, has been launched. The new site - http://www.hepatitiscnews.com - has been developed to deliver accessible information on hepatitis C, an infectious liver disease that affects around 150 million people worldwide. Hepatitiscnews.com features tips on living well with hepatitis...

2013-01-09 04:21:25

BLUE BELL, Pa., Jan. 9, 2013 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) and its development partner VGX International, Inc. (KSE: 011000) will move Inovio's hepatitis C (HCV) DNA vaccine into a phase I/IIa clinical trial by the end of 2013. This advancement is based on outstanding results of a preclinical study which demonstrated for the first time that a multi-antigen SynCon® HCV vaccine can generate robust T-cell responses not only in the blood but, more importantly,...

2013-01-09 05:01:01

Sovereign Health of California has seen a drastic increase in number of patients seeking treatment for heroin addiction. Sovereign Health is committed to combating the spread of hepatitis C by treating heroin addiction through their innovative opiate addiction treatment plan and newly added technology enhanced aftercare monitoring program (T.E.A.M.). Los Angeles, CA (PRWEB) January 08, 2013 Heroin is the most common name for an illegal and often more potent form of morphine, a drug used to...

2013-01-08 14:51:39

A metanalysis published in BioMed Central's open access journal BMC Medicine has confirmed that polymorphisms (SNP) in the gene coding for interleukin-28 (IL28B) influence natural hepatitis C viral (HCV) clearance and response to pegylated interferon-α plus ribavirin (PEG-IFN/RBV). Information about IL28B genotype could be used to provide personalized medicine and target treatment options effectively. Over 200 million people worldwide are chronically infected with hepatitis C...

2013-01-08 08:30:31

SAN DIEGO, Jan. 8, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chief Executive Officer Jim Joyce will give a corporate presentation today at Biotech Showcase 2013. The presentation is scheduled to start at 4:45 p.m. Pacific Standard Time and can be accessed online at http://www.media-server.com/m/p/54bc8kj7. The conference is being held in San Francisco at the Parc 55 Wyndham Union Square Hotel. (Photo:...

2013-01-03 08:25:52

SAN DIEGO, Jan. 3, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that it has submitted an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) that requests permission to initiate a clinical feasibility study of Hepatitis-C (HCV) infected individuals enrolled to receive Hemopurifier®...

2013-01-02 16:22:23

WORCESTER, Mass., Jan. 2, 2013 /PRNewswire/ -- Microbiotix, Inc., a privately-held, clinical stage biopharmaceutical company engaged in the discovery and development of novel small molecule anti-infective drugs, announced today that it has entered into an exclusive licensing agreement with Merck, known as MSD outside the United States and Canada. As part of this agreement, Microbiotix gains worldwide rights to develop, manufacture and commercialize MBX-700 and MBX-701 (formerly SCH 900942...

2012-12-28 15:29:38

Researchers at the University of Colorado School of Medicine have figured out intimate details of how the hepatitis C virus takes over an invaded cell, a breakthrough that could point to way for new treatments for the virus. Hep C hijacks the machinery by which a cell makes proteins and uses it instead to create proteins for the virus. Over the last two decades, researchers have figured out that Hep C uses an RNA molecule to do this. Now they're trying to fill in the details. One key...

2012-12-26 12:57:42

Among patients with chronic hepatitis C virus infection and advanced hepatic fibrosis (development of excess fibrous connective tissue), sustained virological response (SVR) to interferon-based treatment was associated with a lower risk of all-cause mortality compared with patients without SVR, according to a study in the December 26 issue of JAMA. "Chronic hepatitis C virus (HCV) infection is a major cause of cirrhosis, hepatocellular carcinoma (HCC), and end-stage liver disease. The...


Latest hepatitis C Reference Libraries

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

More Articles (1 articles) »